tradingkey.logo
tradingkey.logo
Search

Insight Molecular Diagnostics Ord Shs

IMDX
Add to Watchlist
4.650USD
+0.050+1.09%
Close 07-31 16:00ETQuotes delayed by 15 min
150.15MMarket Cap
LossP/E TTM

IMDX Financials

See Insight Molecular Diagnostics Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Insight Molecular Diagnostics Ord Shs Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.12/-0.26
Revenue / Forecast
32.00K/300.00K
Period
FY2025 Earnings
Revenue(YoY)
4.05M
115.58%
EPS(YoY)
-1.65
64.65%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
Financial Indicators
EPS
---0.12
---0.72
---0.34
Revenue
--32.00K
--1.14M
--260.00K
Net Profit
---4.29M
---22.95M
---10.85M
Net Margin
---13406.25%
---2015.36%
---4174.62%
Gross Margin
--46.88%
--43.55%
--53.46%
Debt to assets ratio
--2.27%
--4.12%
--2.27%
Revenue
--32.00K
--1.14M
--260.00K
Operating profit
---10.33M
---9.95M
---7.67M
Net Profit
---4.29M
---22.95M
---10.85M
Current assets
--30.52M
--15.31M
--21.39M
Total current liabilities
--12.01M
--12.07M
--7.66M
Total assets
--40.43M
--25.76M
--43.94M
Total liabilities
--51.12M
--57.22M
--53.13M
Total equity
---10.69M
---31.46M
---9.20M
Net operating income
---7.64M
---5.54M
---4.50M
Net investment
---613.00K
---1.48M
---1.05M
Net financing
--24.70M
---252.00K
---120.00K

FAQs

What is the total revenue of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its total revenue reached 4.05M, with a year-on-year change of 1.88M.

What are the current assets of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its current assets were 15.31M, with a year-on-year change of 30.16.

What are the total assets of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its total assets of Insight Molecular Diagnostics Ord Shs were 25.76M, with a year-on-year change of -26.58.

What are the total liabilities of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its total liabilities of Insight Molecular Diagnostics Ord Shs were 57.22M, with a year-on-year change of 20.83.

What is the total equity of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its total equity of Insight Molecular Diagnostics Ord Shs was -31.46M, with a year-on-year change of -156.35.

What is the net operating income of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its net operating income of Insight Molecular Diagnostics Ord Shs was -30.50M, with a year-on-year change of -31.18.

What is the net investment of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its net investment of Insight Molecular Diagnostics Ord Shs was -3.19M, with a year-on-year change of -522.07.

What is the net financing of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its net financing of Insight Molecular Diagnostics Ord Shs was 28.07M, with a year-on-year change of 37.41.

What is the Earnings Per Share (EPS) of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -1.65, with a year-on-year change of 64.65.

What is the net income of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its net income was -50.22M, with a year-on-year change of 17.57.

What is the net margin of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its net profit margin was -1238.52, with a year-on-year change of 61.60.

What is the gross margin of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its gross margin was 56.67, with a year-on-year change of 44.05.

What is the debt-to-asset ratio of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its debt-to-asset ratio was 4.12, with a year-on-year change of 54.41.

What is the Return on Assets (ROA) of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -165.10, with a year-on-year change of -49.65.

What is the operating profit of Insight Molecular Diagnostics Ord Shs?

According to Insight Molecular Diagnostics Ord Shs's FY2025 earnings report, its operating profit was -30.50M, with a year-on-year change of -31.18.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.